(S,R,S)-AHPC-C10-NH2 is used primarily in biochemical and pharmaceutical research, particularly in controlling protein degradation via the proteasome system (PROTAC). This technology facilitates the removal of unwanted target proteins from cells by designing the molecule to simultaneously bind to the target protein and the proteasome, enabling specific degradation of the target protein. It is a key tool in studying protein degradation pathways and understanding protein function and regulation within cells. Its applications are crucial in developing targeted therapies for diseases involving protein malfunction, such as cancer and neurodegenerative disorders, by targeting proteins involved in cancer cell growth. Additionally, it serves as a valuable reagent in synthesizing more complex molecules for drug discovery and development.